The primary objectives of this study are to determine whether the study drug, anastrozole may
improve six minute walk distance at six months compared to placebo and to assess safety and
side effects up to twelve months in pulmonary arterial hypertension (PAH).
Phase:
Phase 2
Details
Lead Sponsor:
University of Pennsylvania
Collaborators:
Johns Hopkins University National Heart, Lung, and Blood Institute (NHLBI) Rhode Island Hospital Stanford University University of Colorado, Denver Vanderbilt University Washington University School of Medicine